Patent ID: 7547440
Filing Date: 2009-06-16
Classification: A61K,A61P,C07K

Abstract:
1. A method for treating pollinosis caused by tree pollen in springtime, the method comprising administering a peptide to a patient that has pollinosis in the pollen-scattering season, wherein the peptide is derived from Japanese cypress pollen allergen Cha o 2 and consists of: (i) (a) an amino acid sequence selected from the group consisting of SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ IL) NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ TD NO:63, SEQ ID NO:64, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, and SEQ ID NO:80, said amino acid sequence having T-cell stimulating activity; or (i)(b) a fragment of the amino acid sequence of (i)(a), the fragment being selected from fragments of the amino acid sequences listed in (i)(a), wherein each of the fragments has T-cell stimulating activity equivalent to that of the corresponding amino acid sequence of (i)(a); or